Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2020.05.08
关于收到业绩补偿款的公告
2020.04.30
2020年第一季度报告正文
2020.04.30
2020年第一季度报告全文
2020.04.29
深圳市高新投集团有限公司年度审计报告
2020.04.29
第四届董事会第三十三次会议决议公告
2020.04.29
关于召开2019年年度股东大会的通知公告
2020.04.29
关于会计政策变更的公告
2020.04.29
关于为全资子公司提供担保的公告
2020.04.29
关于举行2019年年度报告网上说明会的公告
2020.04.29
2019年度财务决算报告
第一页
上一页
60
61
62
63
64
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
